Hayley is commercial director and general counsel of Apitope International NV an European biotechnology focusing on the development of therapies for autoimmune diseases.

Hayley joined Apitope from the Basel headquarters of Novartis Pharma AG. Hayley was previously a lawyer in the Life Sciences group of Bird & Bird, London specialising in providing advice for a range of spin-outs, biotech and pharmaceutical industry clients.

Prior to joining Bird & Bird, she was Head of Commercial Legal Affairs within the commercial business team at the Centre for Applied Microbiology and Research (CAMR) in Salisbury UK and was responsible for companywide legal and IP matters. After obtaining both a PhD in Microbiology and a M.Sc. in intellectual property from the University of London, Hayley joined University College London Ventures for five years and was responsible for the development, management and commercialisation of inventions in the life sciences sector.

Hayley is president of LES Britain & Ireland and vice chair of the LESI life sciences committee.